Wealthfront’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $5.33M | Sell |
56,322
-10,036
| -15% | -$949K | 0.05% | 57 |
|
|
2018
Q2 | $6.15M | Sell |
66,358
-13,248
| -17% | -$1.23M | 0.06% | 49 |
|
|
2018
Q1 | $7.54M | Sell |
79,606
-551
| -0.7% | -$52.2K | 0.08% | 43 |
|
|
2017
Q4 | $7.75M | Buy |
80,157
+10,215
| +15% | +$988K | 0.09% | 38 |
|
|
2017
Q3 | $6.22M | Buy |
69,942
+7,875
| +13% | +$700K | 0.08% | 41 |
|
|
2017
Q2 | $4.5M | Buy |
62,067
+10,832
| +21% | +$785K | 0.07% | 52 |
|
|
2017
Q1 | $3.34M | Buy |
51,235
+1,751
| +4% | +$114K | 0.06% | 62 |
|
|
2016
Q4 | $3.1M | Buy |
49,484
+5,626
| +13% | +$352K | 0.07% | 51 |
|
|
2016
Q3 | $2.77M | Buy |
43,858
+4,228
| +11% | +$267K | 0.07% | 57 |
|
|
2016
Q2 | $2.45M | Buy |
39,630
+6,293
| +19% | +$390K | 0.07% | 55 |
|
|
2016
Q1 | $1.9M | Buy |
33,337
+14,280
| +75% | +$816K | 0.06% | 62 |
|
|
2015
Q4 | $1.13M | Buy |
19,057
+4,873
| +34% | +$289K | 0.04% | 79 |
|
|
2015
Q3 | $772K | Sell |
14,184
-5,145
| -27% | -$280K | 0.03% | 94 |
|
|
2015
Q2 | $1.3M | Buy |
19,329
+10,021
| +108% | +$673K | 0.05% | 45 |
|
|
2015
Q1 | $545K | Sell |
9,308
-622
| -6% | -$36.4K | 0.03% | 78 |
|
|
2014
Q4 | $650K | Buy |
9,930
+2,815
| +40% | +$184K | 0.04% | 56 |
|
|
2014
Q3 | $411K | Buy |
7,115
+2,284
| +47% | +$132K | 0.03% | 67 |
|
|
2014
Q2 | $281K | Buy |
4,831
+1,549
| +47% | +$90.1K | 0.02% | 72 |
|
|
2014
Q1 | $171K | Buy |
+3,282
| New | +$171K | 0.02% | 68 |
|